Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Agostinetto

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|February 5, 2025
Prognostic implications of risk definitions from the monarchE and NATALEE trialsLuca Arecco, Eva Blondeaux, Marco Bruzzone, et al.
NPJ Breast Cancer|July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
Breast (Edinburgh, Scotland)|August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectivesLeonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Breast (Edinburgh, Scotland)|February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysisLuca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.
Journal for Immunotherapy of Cancer|December 6, 2023
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trialAlex De Caluwe, Emanuela Romano, Philip Poortmans, et al.
Nature Communications|November 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 studyAndreas Papagiannis, Samira Majjaj, Francois P Duhoux, et al.
Cancer Treatment Reviews|May 22, 2026
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposalAldo Caltavituro, Roberto Buonaiuto, Alessandra Longobardi, et al.
NPJ Breast Cancer|December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastasesKatarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
Nature Medicine|June 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trialAlex De Caluwé, Isabelle Desmoulins, Kim Cao, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|February 5, 2025
Prognostic implications of risk definitions from the monarchE and NATALEE trialsLuca Arecco, Eva Blondeaux, Marco Bruzzone, et al.
NPJ Breast Cancer|July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
Breast (Edinburgh, Scotland)|August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectivesLeonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Breast (Edinburgh, Scotland)|February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysisLuca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.
Journal for Immunotherapy of Cancer|December 6, 2023
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trialAlex De Caluwe, Emanuela Romano, Philip Poortmans, et al.
Nature Communications|November 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 studyAndreas Papagiannis, Samira Majjaj, Francois P Duhoux, et al.
Cancer Treatment Reviews|May 22, 2026
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposalAldo Caltavituro, Roberto Buonaiuto, Alessandra Longobardi, et al.
NPJ Breast Cancer|December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastasesKatarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
Nature Medicine|June 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trialAlex De Caluwé, Isabelle Desmoulins, Kim Cao, et al.
Pageof 8